Assessing the performance of 68Ga-Fibroblast activating protein inhibitor-04 (FAPI) PET/CT in the diagnosis of cholangiocarcinoma - A prospective pilot study

被引:0
|
作者
Halanaik, D. [1 ]
Rajaraman, V. [1 ]
Meenakshi, L. Aridhasan [1 ]
Selvaraj, A. Jeba [1 ]
Pottakkat, B. [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-161
引用
收藏
页码:S72 / S73
页数:2
相关论文
共 50 条
  • [31] Molecular imaging of fibroblast activity in pressure overload heart failure using [68 Ga]Ga-FAPI-04 PET/CT
    Guokun Wang
    Qinqin Yang
    Shengyong Wu
    Xudong Xu
    Xiao Li
    Siyu Liang
    Guixia Pan
    Changjing Zuo
    Xianxian Zhao
    Chao Cheng
    Suxuan Liu
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 465 - 474
  • [32] The performance of 68Ga-FAPI-04 PET/CT in head and neck squamous cell carcinoma: a prospective comparison with 18F-FDG PET/CT
    Yaqun Jiang
    Bing Wen
    Chongjiao Li
    Yueli Tian
    Zhiwei Xiao
    Kui Xu
    Diankui Xing
    Zili Yu
    Jing Huang
    Jun Jia
    Yong He
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2114 - 2126
  • [33] The performance of 68Ga-FAPI-04 PET/CT in head and neck squamous cell carcinoma: a prospective comparison with 18F-FDG PET/CT
    Jiang, Yaqun
    Wen, Bing
    Li, Chongjiao
    Tian, Yueli
    Xiao, Zhiwei
    Xu, Kui
    Xing, Diankui
    Yu, Zili
    Huang, Jing
    Jia, Jun
    He, Yong
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2114 - 2126
  • [34] Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [18F]F-FDG PET/CT in Patients with Liver Malignancies
    Dheeratama Siripongsatian
    Chetsadaporn Promteangtrong
    Anchisa Kunawudhi
    Peerapon Kiatkittikul
    Natphimol Boonkawin
    Chatchawarin Chinnanthachai
    Attapon Jantarato
    Chanisa Chotipanich
    Molecular Imaging and Biology, 2022, 24 : 818 - 829
  • [35] Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [18F]F-FDG PET/CT in Patients with Liver Malignancies
    Siripongsatian, Dheeratama
    Promteangtrong, Chetsadaporn
    Kunawudhi, Anchisa
    Kiatkittikul, Peerapon
    Boonkawin, Natphimol
    Chinnanthachai, Chatchawarin
    Jantarato, Attapon
    Chotipanich, Chanisa
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (05) : 818 - 829
  • [36] Commentary to "[68 Ga]Ga-FAPI-04 PET/CT on assessing Crohn's disease intestinal lesions" by Chen and colleagues
    Lovinfosse, Pierre
    Vieujean, Sophie
    Louis, Edouard
    Hustinx, Roland
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (05) : 1278 - 1279
  • [37] 68Ga-Fibroblast Activation Protein Inhibitor, a Promising Radiopharmaceutical in PET/CT to Detect the Primary and Metastatic Lesions of Chromophobe Renal Cell Carcinoma
    Pang, Yizhen
    Wei, Jihong
    Shang, Qihang
    Zhao, Liang
    Chen, Haojun
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (02) : 177 - 179
  • [38] Commentary to “[68 Ga]Ga-FAPI-04 PET/CT on assessing Crohn’s disease intestinal lesions” by Chen and colleagues
    Pierre Lovinfosse
    Sophie Vieujean
    Edouard Louis
    Roland Hustinx
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1278 - 1279
  • [39] 68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT
    Komek, Halil
    Can, Canan
    Guzel, Yunus
    Oruc, Zeynep
    Gundogan, Cihan
    Yildirim, Ozgen Ahmet
    Kaplan, Ihsan
    Erdur, Erkan
    Yildirim, Mehmet Serdar
    Cakabay, Bahri
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (06) : 744 - 752
  • [40] 68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT
    Halil Kömek
    Canan Can
    Yunus Güzel
    Zeynep Oruç
    Cihan Gündoğan
    Özgen Ahmet Yildirim
    İhsan Kaplan
    Erkan Erdur
    Mehmet Serdar Yıldırım
    Bahri Çakabay
    Annals of Nuclear Medicine, 2021, 35 : 744 - 752